The evidence that the DNC (SLC25A19) is not the mitochondrial deoxyribonucleotide carrier

Mitochondrion

Volumn 8, Issue 2, 2008, Pages 103-108

  Kang, Jonghoon ^a   Samuels, David C ^a  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

Antiviral toxicity; AZT; Deoxyribonucleotide transport; HAART; MCPHA; Salvage pathway; ThPP transport

Indexed keywords

ANTIRETROVIRUS AGENT; CARRIER PROTEIN; COCARBOXYLASE; MITOCHONDRIAL DNA; NUCLEOSIDE DERIVATIVE; PROTEIN SLC25A19; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

AMISH; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DETERMINATION; DRUG CYTOTOXICITY; DRUG SAFETY; ENZYME KINETICS; GENE FUNCTION; GENE IDENTIFICATION; GENETIC DISORDER; GENETIC RISK; HEART MITOCHONDRION; HETEROZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROCEPHALY; MITOCHONDRIAL TOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; UNSPECIFIED SIDE EFFECT; YEAST;

EID: 40149090267     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2008.01.001     Document Type: Review

References (39)

1. P.L. Anderson T.N. Kakuda K.A. Lichtenstein The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities Clin. Infect. Dis. 38 2004 743 753
2. M. Barile D. Valenti C. Brizio E. Quagliariello S. Passarella Rat liver mitochondria can hydrolyse thiamine pyrophosphate to thiamine monophosphate which can cross the mitochondrial membrane in a carrier-mediated process FEBS Lett. 435 1998 6 10
3. P.C. Bradshaw J.X. Li D.C. Samuels A computational model of mitochondrial AZT metabolism Biochem. J. 392 2005 363 373
4. P.C. Bradshaw D.C. Samuels A computational model of mitochondrial deoxynucleotide metabolism and DNA replication Am. J. Physiol. Cell Physiol. 288 2005 C989 C1002
5. E.G. Bridges Z.L. Jiang Y.C. Cheng Characterization of a dCTP transport activity reconstituted from human mitochondria J. Biol. Chem. 274 1999 4620 4625
6. D.A. Clayton Replication of animal mitochondrial–DNA Cell 28 1982 693 705
7. W.C. Copeland Inherited mitochondrial diseases of mtDNA replication Annu. Rev. Med. 51 2008 309 324
8. A. del Arco J. Satrustegui New mitochondrial carriers: an overview Cell. Mol. Life Sci. 62 2005 2204 2227
9. V. Dolce G. Fiermonte M.J. Runswick F. Palmieri J.E. Walker The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals Proc. Natl. Acad. Sci. USA 98 2001 2284 2288
10. O. Elpeleg Inherited mitochondrial DNA depletion Pediatr. Res. 54 2003 153 159
11. P. Ferraro L. Nicolosi P. Bernardi P. Reichard V. Bianchi Mitochondrial deoxynucleotide pool sizes in mouse liver and evidence for a transport mechanism for thymidine monophosphate Proc. Natl. Acad. Sci. USA 103 2006 18586 18591
12. S. Floyd C. Favre F.M. Lasorsa M. Leahy G. Trigiante P. Stroebel A. Marx G. Loughran K. O’Callaghan C.M.T. Marobbio D.J. Slotboom E.R.S. Kunji F. Palmieri R. O’Connor The insulin-like growth Factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth Mol. Biol. Cell 18 2007 3545 3555
13. T. Haitina J. Lindblom T. Renstrom R. Fredriksson Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system Genomics 88 2006 779 790
14. R.I. Kelley D. Robinson E.G. Puffenberger K.A. Strauss D.H. Morton Amish lethal microcephaly: a new metabolic disorder with severe congenital microcephaly and 2-ketoglutaric aciduria Am. J. Med. Genet. 112 2002 318 326
15. E.R.S. Kunji The role and structure of mitochondrial carriers FEBS Lett. 564 2004 239 244
16. E.R.S. Kunji A.J. Robinson The conserved substrate binding site of mitochondrial carriers Biochim. Biophys. Acta – Bioenerg. 1757 2006 1237 1248
17. W. Lam C.S. Chen S.L. Ruan C.H. Leung Y.C. Cheng Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake Mol. Pharmacol. 67 2005 408 416
18. W. Lewis Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy Mitochondrion 4 2004 141 152
19. W. Lewis B.J. Day W.C. Copeland Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective Nat. Rev. Drug Discov. 2 2003 812 822
20. W. Lewis C.P. Haase Y.K. Miller B. Ferguson T. Stuart T. Ludaway J. Mcnaught R. Russ J. Steltzer R. Santoianni R. Long G. Fiermonte F. Palmieri Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS Lab. Invest. 85 2005 972 981
21. W. Lewis J.J. Kohler S.H. Hosseini C.P. Haase W.C. Copeland R.J. Bienstock T. Ludaway J. McNaught R. Russ T. Stuart R. Santoianni Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis AIDS 20 2006 675 684
22. M.J. Lindhurst G. Fiermonte S.W. Song E. Struys F. De Leonardis P.L. Schwartzberg A. Chen A. Castegna N. Verhoeven C.K. Mathews F. Palmieri L.G. Biesecker Knockout of Slc25a19 causes mitochondrial thiamine pyrophosphate depletion, embryonic lethality, CNS malformations, and anemia Proc. Natl. Acad. Sci. USA 103 2006 15927 15932
23. M.D. Lynx A.T. Bentley E.E. McKee 3′-azido-3′-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity Biochem. Pharmacol. 71 2006 1342 1348
24. C.M.T. Marobbio M.A. Di Noia F. Palmieri Identification of a mitochondrial transporter for pyrimidine nucleotides in Saccharomyces cerevisiae : bacterial expression, reconstitution and functional characterization Biochem. J. 393 2006 441 446
25. C.M.T. Marobbio A. Vozza M. Harding F. Bisaccia F. Palmieri J.E. Walker Identification and reconstitution of the yeast mitochondrial transporter for thiamine pyrophosphate EMBO J. 21 2002 5653 5661
26. R. Marti Y. Nishigaki M.R. Vila M. Hirano Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders Clin. Chem. Lab. Med. 41 2003 845 851
27. C.K. Mathews DNA precursor metabolism and genomic stability FASEB J. 20 2006 1300 1314
28. F. Palmieri The mitochondrial transporter family (SLC25): physiological and pathological implications Pflugers Arch. 447 2004 689 709
29. M. Pinti P. Salomoni A. Cossarizza Anti-HIV drugs and the mitochondria Biochim. Biophys. Acta – Bioenerg. 1757 2006 700 707
30. A.S. Ray Intracellular interactions between nucleos(t)ide inhibitors of HIV reverse transcriptase AIDS Rev. 7 2005 113 125
31. M.J. Rosenberg R. Agarwala G. Bouffard J. Davis G. Fiermonte M.S. Hilliard T. Koch L.M. Kalikin I. Makalowska D.H. Morton E.M. Petty J.L. Weber F. Palmieri R.I. Kelley A.A. Schaffer L.G. Biesecker Mutant deoxynucleotide carrier is associated with congenital microcephaly Nat. Genet. 32 2002 175 179
32. A. Saada Deoxyribonucleotides and disorders of mitochondrial DNA integrity DNA Cell Biol. 23 2004 797 806
33. A. Saada A. Shaag O. Elpeleg mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency Mol. Genet. Metab. 79 2003 1 5
34. S.D. Sales P.G. Hoggard D. Sunderland S. Khoo C.A. Hart D.J. Back Zidovudine phosphorylation and mitochondrial toxicity in vitro Toxicol. Appl. Pharmacol. 177 2001 54 58
35. D.C. Samuels Mitochondrial AZT metabolism IUBMB Life 58 2006 403–408
36. Q. Song C.K. Singleton Mitochondria from cultured cells derived from normal and thiamine-responsive megaloblastic anemia individuals efficiently import thiamine diphosphate BMC Biochem. 3 2002 8
37. J.W. Taanman J.R. Muddle A.C. Muntau Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts Hum. Mol. Genet. 12 2003 1839 1845
38. T.W. Traut Physiological concentrations of purines and pyrimidines Mol. Cell. Biochem. 140 1994 1 22
39. M. Zeviani S. Di Donato Mitochondrial disorders Brain 127 2004 2153 2172